Advantage specialist: tumor
Established in 1973, Charing Cross Hospital trophoblastic tumor screening and treatment center has monitored over 30,000 patients with hydatidiform mole and trophoblastic tumor, and diagnosed and treated 3,400 patients with trophoblastic tumor.
This is a team of unity and cooperation, precision and efficiency, its core members are less than ten people, the work includes: (1) diagnosis of hydatidiform mole, registration and follow-up; (2) diagnosis and treatment of trophoblastic tumor patients and long-term follow-up; Clinical research of trophoblastic diseases.
Currently, about 1200 new cases of hydatidiform mole are registered at the center every year, and about 100 new cases of trophoblastic tumor are diagnosed and treated.